Tag: Insurance: Medicare
Broader Formulary Coverage Linked to Lower Odds of MS Relapse
Lower odds of relapse seen among Medicare beneficiaries in prescription drug plans, Medicare Advantage Prescription Drug plans
Physicians Exiting Traditional Medicare Accelerated From 2010 to 2023
Rates higher during and since the pandemic, particularly among primary care physicians
Mortality Up With Loss of Low-Income Subsidy for Drugs
Mortality difference amplified for users of medications for cardiovascular disease, chronic lung disease, HIV
President Signs Executive Order to Lower Some Drug Costs
Order expected to affect specific medications covered under Medicare that are administered in a health care setting
Mehmet Oz Confirmed as Head of Centers for Medicare & Medicaid Services
New appointments also made to lead the NIH and as Commissioner of Food and Drugs at the FDA
Disparities Seen in Older Adults’ Access to Rehab After Hospitalization for TBI
Some older adults receive no outpatient rehabilitation or home health care following acute care hospitalization and community discharge
Dr. Oz Accused of Underpaying Medicare Taxes Ahead of Nomination Hearing
Rise in Telemedicine Tied to Modest Decrease in Low-Value, Point-of-Care Testing
Findings seen among Medicare beneficiaries, but no differences seen in low-value spending overall
Trump Ends Push to Slash Prescription Drug Costs
